Doctor profile · Federal record
Dr. Robert Havard, MD
Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology (Internal Medicine) Physician · Visalia, CA
- NPI 1225002694
- Accepts Medicare
- MIPS 95.4 / 100 · 2023
- 46 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
4945 W Cypress Ave, Ste C
Visalia, CA 93277
(559) 624-3000
fax (559) 635-4006
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- March 7, 2023
- Year of graduation
- 1980 — 46 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- California #92313
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1225002694. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
143,212
Distinct HCPCS
10
Medicare allowed
$2,456,142
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units | 20,040 | 75 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 19,400 | 19 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 17,700 | 24 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 16,538 | 17 | $0 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 16,500 | 15 | $1 | |
J9299 |
Injection, nivolumab, 1 mg | 9,000 | 11 | $30 | |
J0897 |
Injection, denosumab, 1 mg | 7,560 | 15 | $23 | |
Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 7,020 | 14 | $30 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 5,939 | 79 | $0 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 5,120 | 13 | $7 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 3,113. This provider delivers 46× the peer median.Open Payments
Industry payments received
All-time total
$3,831
Transactions
103
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 25 | $1,467.70 | |
| GlaxoSmithKline, LLC. | 14 | $347.87 | |
| Janssen Biotech, Inc. | 10 | $174.29 | |
| AstraZeneca Pharmaceuticals LP | 7 | $164.86 | |
| Merck Sharp & Dohme LLC | 6 | $144.86 | |
| Celgene Corporation | 8 | $133.54 | |
| Daiichi Sankyo Inc. | 5 | $121.28 | |
| GENZYME CORPORATION | 3 | $100.07 | |
| Eisai Inc. | 4 | $96.86 | |
| Exelixis Inc. | 4 | $89.42 | |
| SOBI, INC | 3 | $75.81 | |
| PFIZER INC. | 3 | $73.46 | |
| Genentech USA, Inc. | 4 | $70.96 | |
| ARRAY BIOPHARMA INC | 4 | $64.26 | |
| ACCORD HEALTHCARE, INC. | 3 | $63.45 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,238
Patients
414
Total drug cost
$1,245,242
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 341 | 90 | $7,332 |
| Prednisone | Generic | 111 | 46 | $768 |
| Tamoxifen Citrate | Generic | 75 | 21 | $2,678 |
| Ondansetron Hcl | Generic | 72 | 44 | $713 |
| Pantoprazole Sodium | Generic | 72 | 20 | $625 |
| Procrit (Epoetin Alfa) | Brand | 68 | 14 | $329,189 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 67 | 29 | $1,296 |
| Prochlorperazine Maleate | Generic | 61 | 43 | $864 |
| Gabapentin | Generic | 59 | 11 | $839 |
| Furosemide | Generic | 58 | 20 | $175 |
Frequently asked questions
What is Dr. Robert Havard's medical specialty?
Dr. Robert Havard practices Medical Oncology Physician in Visalia, CA.
Where does Dr. Robert Havard practice?
Dr. Robert Havard practices at 4945 W Cypress Ave, Visalia, CA 93277. Office phone: 5596243000.
What is Dr. Robert Havard's NPI?
Dr. Robert Havard's National Provider Identifier (NPI) is 1225002694, issued by NPPES.
Does Dr. Robert Havard accept Medicare assignment?
Yes. Dr. Robert Havard accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Robert Havard commonly perform?
Top Medicare-reported procedures in 2023: Injection, heparin sodium, (heparin lock flush), per 10 units (HCPCS J1642); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.